All In Biotech

Free tool

FAERS Monitor: Tirosint-Sol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 206977 or its brand name (Tirosint-Sol, Levothyroxine Sodium). Reports on generic versions are filed under their own applications.

Reports

105,950

Serious

71,861

68% of reports

Hospitalization

39,651

Death reported

8,452

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue8,794
  • nausea7,563
  • diarrhoea6,822
  • headache6,722
  • dyspnoea6,540
  • drug ineffective5,752
  • pain5,521
  • dizziness5,325
  • vomiting4,644
  • asthenia4,534
  • malaise4,354
  • off label use4,266
  • fall4,189
  • arthralgia4,177
  • pruritus3,670

Reports by year received

View as table
YearReports
20042,043
20052,018
20062,180
20072,761
20084,015
20093,824
20104,310
20116,158
20126,850
20131,453
20141,810
20152,608
20163,443
20173,901
20184,524
20194,399
20205,903
20216,176
20227,733
20237,405
20247,735
20258,648
20266,052

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,948,209 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
fallSignal4,1892.52.43,844
astheniaSignal4,5342.42.33,764
dyspnoeaSignal6,5402.32.34,926
fatigueSignal8,7942.32.26,316
headacheSignal6,7222.12.14,165
dizzinessSignal5,3252.12.13,240
diarrhoeaSignal6,8222.12.14,064
arthralgiaSignal4,1772.01.92,122
malaise4,3542.01.92,136
vomiting4,6442.01.92,247
nausea7,5631.91.93,349
pruritus3,6701.91.81,589
pain5,5211.81.71,969
off label use4,2661.00.95
drug ineffective5,7520.90.8127

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.